S62 New Roles for Thyroid Hormone in Metabolic Regulation and Disease

Program: Symposia
Basic/Translational Session
Saturday, March 7, 2015: 4:30 PM-6:00 PM
Room 6F (San Diego Convention Center)
**This session is eligible for CME credit**

Chair:
Sheue-Yann Cheng, PHD, NIH - Nat'l Cancer Inst, Bethesda, MD

Nothing to Disclose: SYC Disclosure Not Provided: AMD, SAH

Newer recognized targets and mechanisms of action for thyroid hormone include skeletal muscle and liver autophagy, as well as a significant impact on kidney function. Thyroid hormone action on muscle and liver in animal models, and the association of hypothyroidism with chronic renal disease in humans, will be discussed to provide examples of the emerging roles of thyroid hormone. Many of these new roles provide novel therapeutic targets for metabolic diseases.

4:30 PM
Paul Michael Yen, MD, Cardiovascular/Metab Disorder Program, Duke-NUS Graduate Med School, Singapore, Singapore
Nothing to Disclose: PMY
4:50 PM
Connie Rhee, MD, Division of Nephrology and Hypertension, University of California Irvine, Orange, CA
Nothing to Disclose: CR
5:10 PM
Anna Milanesi, MD, PhD, Medicine, University of California - Los Angeles, Los Angeles, CA
Nothing to Disclose: AM
5:30 PM
P Reed Larsen, FACP, FRCP, MA, MD, Dept of Med, Div of Endodocrinology, diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA
Nothing to Disclose: PRL
See more of: Symposia